Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Preclinical crawled date : 2022 - 03 - 08 save search
Theseus Pharmaceuticals to Present Preclinical Data Characterizing Next-Generation Epidermal Growth Factor Receptor (EGFR) Inhibitors at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
THRX | $4.06 0.49% 0
|
|
| O: 2.4%
H: 8.76%
C: 4.68%
america als derm research preclinical cancer growth pre-clinical
Omega Therapeutics to Present Preclinical Data for OTX-2002 at the American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
OMGA | $2.42 -5.28% -5.58% 360K
|
|
| O: 2.36%
H: 0.0%
C: 0.0%
otx-2002 america research therapeutics preclinical cancer pre-clinical
Arcellx Announces Pre-Clinical Data Presentation for ACLX-002, a Novel CD123-targeted Universal CAR-T Cell Therapy for Relapsed or Refractory Acute Myeloid Leukemia at the American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
ACLX | $54.5 1.77% 1.74% 600K
|
|
| O: 2.8%
H: 3.41%
C: -6.98%
aclx-002 america myeloid leukemia car-t leukemia research presentation cel pre-clinical therapy cancer t-cell preclinical acute myeloid leukemia
Nuvalent to Present New Preclinical Data on ROS1-Selective Inhibitor NVL-520 and ALK-Selective Inhibitor NVL-655 at AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 23:00) - prnewswire.com
NUVL | $62.97 -1.99% -2.03% 610K
|
|
| O: 2.01%
H: 7.27%
C: -2.9%
nvl-520 preclinical pre-clinical
Adagene Announces Four Poster Presentations on Robust Preclinical Pipeline of Antibody-Based Therapeutics at Upcoming American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 23:00) - globenewswire.com
ADAG | $2.53 -0.37% 1.8K
|
Manufacturing
|
| O: 1.25%
H: 8.84%
C: -2.24%
america pos research therapeutics presentation preclinical cancer antibody pre-clinical
Genocea to Present Clinical and Preclinical Data at AACR Annual Meeting
Published: 2022-03-08 (Crawled : 23:00) - globenewswire.com
GNCA | $0.051
|
Health Technology
|
| O: 3.74%
H: 9.01%
C: 7.21%
preclinical pre-clinical
Zentalis Pharmaceuticals to Present New Clinical and Preclinical Data at the AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
ZNTL | $12.55 -1.26% -1.27% 680K
|
Health Technology
|
| O: 3.2%
H: 8.26%
C: 6.25%
als preclinical pre-clinical
Bolt Biotherapeutics to Present Updates for Three Preclinical Immuno-Oncology Pipeline Programs at AACR Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
BOLT | $1.15 3.6% 3.48% 89K
|
|
| O: 3.38%
H: 13.07%
C: 11.44%
program therapeutics preclinical iot pre-clinical
Kronos Bio’s Investigational CDK9 Inhibitor KB-0742 to be Featured in Four Preclinical Poster Presentations at American Association for Cancer Research Annual Meeting 2022
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
KRON | $1.01 -2.89% -2.97% 210K
|
Health Technology
|
| O: 2.13%
H: 6.85%
C: 6.25%
kb-0742 america pos research presentation preclinical cancer pre-clinical
Theratechnologies to Present Three Posters at AACR Including New In Vivo TH1902 Preclinical Data Demonstrating Tumor Growth Inhibition of Human Cancer Stem-Like Cells (CD133+) in Both Triple-Negative Breast and Ovarian Cancers
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
THTX | $1.32 -12.78% 10K
|
Health Technology
|
| O: 1.53%
H: 2.64%
C: 0.0%
th1902 pos ovarian cancer cel preclinical cancer growth negative pre-clinical
Sana Biotechnology to Present Preclinical Data on its Engineered Hypoimmune Allogeneic CAR T Cells at the 2022 American Association for Cancer Research Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
SANA | $7.74 -6.3% -6.72% 1.9M
|
|
| O: 3.73%
H: 6.92%
C: 5.94%
america technology research cel preclinical cancer biotech iot t-cell pre-clinical
Nkarta to Present Preclinical Data from Engineered NK Cell Platform at the American Association for Cancer Research 2022 Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
NKTX | $7.78 -1.02% -1.03% 680K
|
Health Technology
|
| O: 1.46%
H: 6.9%
C: 6.49%
america research cel preclinical cancer platform pre-clinical
ESSA Pharma to Present Preclinical Data for its First Generation of Androgen Receptor N-Terminal Domain Degraders at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - prnewswire.com
EPIX | $6.67 -5.66% -6.0% 36K
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
america research preclinical cancer pre-clinical
Jazz Pharmaceuticals to Present Pan-RAF Inhibitor Pre-Clinical Data at American Association for Cancer Research (AACR) 2022 Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - prnewswire.com
JAZZ | $109.3 2.05% 2.01% 560K
|
Health Technology
|
| O: -0.02%
H: 1.61%
C: 0.31%
america als research pre-clinical cancer preclinical
Nurix Therapeutics to Present Preclinical Data from Its Novel BTK Degrader (NX-2127) and CBL-B Inhibitor (NX-0255) Programs at the American Association for Cancer Research Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
NRIX 2 d | $14.43 2.49% 2.43% 970K
|
Health Technology
|
| O: 3.92%
H: 3.77%
C: 2.25%
nx-2127 america program research therapeutics preclinical cancer pre-clinical
HOOKIPA to present new preclinical, translational, and clinical biomarker data at AACR further supporting the potential of arenaviral platform in oncology
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
HOOK | $0.7695 0.92% 0.91% 170K
|
Health Technology
|
| O: 3.12%
H: 4.24%
C: 0.0%
preclinical potential platform pre-clinical biomarkers
Tango Therapeutics Announces Presentation of Preclinical Data on TNG908, USP1 Inhibitor Program and Discovery Platform in Three Abstracts Accepted at AACR 2022 Annual Meeting
Published: 2022-03-08 (Crawled : 22:00) - globenewswire.com
TNGX | $7.39 -0.94% -0.95% 400K
|
|
| O: 0.81%
H: 2.89%
C: 0.0%
tng908 program therapeutics presentation preclinical platform pre-clinical
OccamzRazor announces closing of $6.1M financing round to launch their AI-enabled discovery pipeline and advance preclinical development in Parkinson's.
Published: 2022-03-08 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
parkinson preclinical pre-clinical
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.